Lanosterol converting enzyme

Cho SY, Kim JH, Paik YK (1998) Cholesterol biosynthesis from lanosterol differential inhibition of sterol delta 8-isomerase and other lanosterol-converting enzymes by tamoxifen. Mol Cells 8(2) 233-239... 

S. Y. Cho, J-H. Kim, and Y-K. Paik Cholesterol biosynthesis from lanosterol Differential inhibition of sterol A -isomerase and other lanosterol-converting enzymes by tamoxifen. Molecules and Cells 8,233 (1998). 

The compensatory effect of cholesterol observed in D407 cells have also been demonstrated in other cell lines (Cho et al. 1998 Holleran et al. 1998) and may well be a consequence of tamoxifen-induced severe inhibition of lanosterol (to cholesterol)-converting enzymes. In rat liver preparations and CHO cells, sterol A8-isomerase (IC50 0.21-0.15. iM) was the most sensitive... 

Squalene monooxygenase, an enzyme bound to the endoplasmic reticulum, converts squalene to squalene-2,3-epoxide (Figure 25.35). This reaction employs FAD and NADPH as coenzymes and requires Og as well as a cytosolic protein called soluble protein activator. A second ER membrane enzyme, 2,3-oxidosqualene lanosterol cyclase, catalyzes the second reaction, which involves a succession of 1,2 shifts of hydride ions and methyl groups. 

Although lanosterol may appear similar to cholesterol in structure, another 20 steps are required to convert lanosterol to cholesterol (Figure 25.35). The enzymes responsible for this are all associated with the endoplasmic reticulum. The primary pathway involves 7-dehydroeholesterol as the penultimate intermediate. An alternative pathway, also composed of many steps, produces the intermediate desmosterol. Reduction of the double bond at C-24 yields cholesterol. Cholesterol esters—a principal form of circulating cholesterol—are synthesized by acyl-CoA cholesterol acyltransferases (ACAT) on the cytoplasmic face of the endoplasmic reticulum. 

The biomimetic approach to total synthesis draws inspiration from the enzyme-catalyzed conversion of squalene oxide (2) to lanosterol (3) (through polyolefinic cyclization and subsequent rearrangement), a biosynthetic precursor of cholesterol, and the related conversion of squalene oxide (2) to the plant triterpenoid dammaradienol (4) (see Scheme la).3 The dramatic productivity of these enzyme-mediated transformations is obvious in one impressive step, squalene oxide (2), a molecule harboring only a single asymmetric carbon atom, is converted into a stereochemically complex polycyclic framework in a manner that is stereospecific. In both cases, four carbocyclic rings are created at the expense of a single oxirane ring. 

By far the most impressive example of electrophilic addition in natural prodnct formation is in the biosynthesis of steroids. The snbstrate sqnalene oxide is cyclized to lanosterol in a process catalysed by a single enzyme. Lanosterol is then converted into the primary animal-steroid cholesterol. Sqnalene oxide comes from sqnalene, which is itself formed throngh a combination of two molecules of farnesyl diphosphate. 

The all-tra 5 -squalene (C30H50), discovered in shark liver oil in the 1920s, is a triterpene, but one in which the isoprene rule at violated in one point. Rather than a head-to-tail arrangement of six units of isoprene, there appear to be farnesyl units that have been connected tail to tail. Almost aU steroids are biosynthesized from cholesterol. Cholesterol is biosynthesized from squalene, which is first converted to lanosterol. The conversion of squalene to the steroid skeleton is an oxirane, squalene-2,3-oxide, which is transformed by enzymes into lanosterol, a steroid alcohol naturally found in wool fat. The whole process is highly stereoselective. 

Squalene is an important biological precursor of many triterpenoids, one of which is cholesterol. The first step in the conversion of squalene to lanosterol is epoxidation of the 2,3-douhle bond of squalene. Acid-catalysed ring opening of the epoxide initiates a series of cyclizations, resulting in the formation of protesterol cation. Elimination of a C-9 proton leads to the 1,2-hydride and 1,2-methyl shifts, resulting in the formation of lanosterol, which in turn converted to cholesterol by enzymes in a series of 19 steps. 

The synthesis of all isoprenoids starts with acetyl-CoA, which in a series of six different enzyme reactions is converted into isopentenyl-diphosphate (-PP), the basic C-5 isoprene unit that is used for the synthesis of all subsequent isoprenoids (Fig. 5.1.1). At the level of farnesyl-PP the pathway divides into several branches that are involved in the production of the various isoprenoid end products. One of the major branches involves the cholesterol biosynthetic part of the pathway, of which squalene is the first committed intermediate in the production of sterols. Following cycliza-tion of squalene, lanosterol is produced. To eventually produce cholesterol from la-... 

In the biogenesis of steroids, the enzyme-catalyzed polycyclization of squalene (225) produces the tetracyclic substance lanosterol (225) which is eventually converted into cholesterol (227) Eschenmoser, Stork, and their co-workers (80-82) have proposed that the squalene-1anosterol conversion can be rationalized on the basis of stereoelectronic effects. The stereochemical course of this biological cyclization (83, 84) can be illustrated by considering the transformation of squalene oxide (228) (an intermediate in the biosynthesis of cholesterol (83, 84)) into dammaradienol 229. This transfor-... 

Role of squalene in the biosynthesis of steroids. The biosynthesis of steroids starts with epoxidation of squalene to squalene-2,3-epoxide. The opening of this epoxide promotes cyclization of the carbon skeleton under the control of an enzyme. The cyclized intermediate is converted to lanosterol, then to other steroids. 

Stereospecific 2,3-epoxidation of squalene, followed by a nonconcerted carbocationic cyclization and a series of carbocationic rearrangements, forms lanosterol [79-65-0] (77) in the first steps dedicated solely toward steroid synthesis (109,110). Several biomimetic, cationic cydizations to form steroids or steroidlike nuclei have been observed in the laboratory (111), and the total synthesis of lanosterol has been accomplished by a carbocation—olefin cydization route (112). Through a complex series of enzyme-catalyzed reactions, lanosterol is converted to cholesterol (2). Cholesterol is the principal starting material for steroid hormone biosynthesis in animals. The cholesterol biosynthetic pathway is composed of at least 30 enzymatic reactions. Lanosterol and squalene appear to be normal constituents, in trace amounts, in tissues that are actively synthesizing cholesterol. 

The final stage of cholesterol biosynthesis starts with the cyclization of squalene (Figure 26.11). Squalene is first activated by conversion into squalene epoxide (2,3-oxi-dosqualene) in a reaction that uses O2 and NADPH. Squalene epoxide is then cyclized to lanosterol by oxi-dosqualene cyclase. This remarkable transformation proceeds in a concerted fashion. The enzyme holds squalene epoxide in an appropriate conformation and initiates the reaction by protonating the epoxide oxygen. The carbocation formed spontaneously rearranges to produce lanosterol. Lanosterol is converted into cholesterol in a... 

Step 4 A series of enzyme-catalyzed reactions converts lanosterol to cholesterol. The three highlighted methyl gronps in the stmctnral formnla of lanosterol are lost via separate multistep operations, the C-8 and C-24 double bonds are reduced, and a new double bond is introduced at C-5. 

Nineteen discrete reactions are used to convert lanosterol to cholesterol. All of the enzymes necessary for these reactions are embedded in the microsomal membrane. Some of these proteins have been solubilized and purified. However, many questions of the mechanism and enzymology of these reactions remain to be answered. 

The enzymes responsible for the conversion of lanosterol to cholesterol, as were those for the conversion of farnesyl pyrophosphate to squalene and lanosterol, are all integral membrane-bound proteins of the endoplasmic reticulum. Many have resisted solubiUzation, some have been partially purified, and several have been obtained as pure proteins. As a consequence, much of the enzymological and mechanistic studies have been done on impure systems and one would anticipate a more detailed and improved understanding of these events as more highly purified enzymes become available. Many approaches have been taken to establish the biosynthetic route that sterols follow to cholesterol. Some examples are synthesis of potential intermediates, the use of inhibitors, both of sterol transformations and of the electron transfer systems, and by isotope dilution experiments. There is good evidence that the enzymes involved in these transformations do not have strict substrate specificity. As a result, many compounds that have been found to be converted to intermediates or to cholesterol may not be true intermediates. In addition, there is structural similarity between many of the intermediates so that alternate pathways and metabolites are possible. For example, it has been shown that side-chain saturation can be either the first or the last reaction in the sequence. Fig. 21 shows a most probable series of intermediates for this biosynthetic pathway. 

Enzymes of lanosterol metabolism are enhanced in yeast grown semi-anaerobi-cally. A cytochrome P-450 that bound lanosterol was isolated from this yeast and purified to near homogeneity. This purified (90%) cytochrome P-450 when incubated in the presence of dioxygen, NADPH, and pure NADPH-cytochrome P-450 reductase converted lanosterol to 4,4-dimethyl-cholesta-8,14,24-trien- -ol. This system was also inhibited by CO. The interesting point raised here is that, with nearly pure proteins, apparently one cytochrome P-450 is catalyzing three hydroxylation reactions [107]. 

Squalene is converted into the first sterol, lanosterol, by the action of squalene epoxidase and oxidosqualene lanosterol cyclase. The catalytic mechanism for the cyclase s four cyclization reactions was revealed when the crystal stmcture of the human enzyme was obtained (R. Thoma, 2004). Oxidosqualene lanosterol cyclase is considered an attractive target for developing inhibitors of the cholesterol biosynthetic pathway because its inhibition leads to the production of 24,25-epoxycholesterol (M.W. Huff, 2005). This oxysterol is a potent ligand activator of the liver X receptor (LXR) and leads to expression of several genes that promote cellular cholesterol efflux, such as ABCAl, ABCG5, and ABCG8 (Section 4.1). Thus, inhibitors of oxidosqualene lanosterol cyclase could be therapeutically advantageous because they would reduce cholesterol synthesis and promote cholesterol efflux (M.W. Huff, 2005). 

Lanosterol is converted to cholesterol by a series of oxidations, reductions, and demethylations. The required enzyme reactions have been defined and metabolic intermediates identified however, the precise sequence of reactions between lanosterol and cholesterol remains to be established [7] (Fig. 4). There is evidence for two alternative pathways that differ in the point at which the A24 double bond is reduced (Section 2.3). Both 7-dehydrocholesterol (DHC) and desmosterol have been postulated to be the... 

Lanosterol is converted into cholesterol in a series of nineteen enzyme reactions [18]. The production of cholesterol from lanosterol involves the reduction of the double bond at C-24, demethylations of ge/w-dimethyl at C-4 and a tertiary methyl at C-l4, and isomerization of the double bond from C-8 to C-l. Two major pathways involving the same enzymes have been proposed [16-18]. Cholesterol biosynthetic pathway is outlined in... 

Azoles are fungicidal and interfere with the synthesis of ergosterol by inhibiting 14-a-demethylase, a fungal P450 enzyme, which converts lanosterol to ergosterol... 

---